In one family, the diagnosis of iPPSD3 was based on the lack of AHO manifestations together with PTH resistance (hypocalcaemia with increased serum PTH levels) and molecular confirmation (Table 1). Here, PTH is linked to pseudohypoparathyroidism type 1A.